Pieter Johannes Gaillard
Affiliations: | Leiden University, Leiden, Netherlands |
Area:
Celbiology, HistologyGoogle:
"Pieter Johannes Gaillard"Bio:
(1907 - 1992)
http://www.biografischportaal.nl/en/persoon/98576433
http://www.dwc.knaw.nl/DL/levensberichten/PE00000325.pdf
Cross-listing: Chemistry Tree
Parents
Sign in to add mentor| Siegfried T. Bok | grad student | 1931 | Leiden (Neurotree) | |
| (Het ontogenetisch veranderen van de samenstelling der lichaamsvochten, gezien den groei en de differentiatie van daarin gekweekte weefsels) | ||||
Children
Sign in to add trainee| Aart Schaberg | grad student | 1951 | Leiden |
| Lourens Anton Joosse | grad student | 1956 | Leiden (Physiology Academic Tree) |
| Jan Oort | grad student | 1957 | Leiden (Anatomy Tree) |
| Wilhelm Adolf de Voogd van der Straaten | grad student | 1958 | Leiden (ID Tree) |
| Martin Rodbell | research scientist | 1961 | Leiden (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hu Y, Gaillard PJ, de Lange ECM, et al. (2019) Targeted Brain Delivery of Methotrexate by Glutathione PEGylated Liposomes: How can the Formulation Make a Difference? European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V |
| Himawan E, Ekström P, Buzgo M, et al. (2019) Drug delivery to retinal photoreceptors. Drug Discovery Today |
| Hu Y, Gaillard PJ, Rip J, et al. (2018) In Vivo Quantitative Understanding of PEGylated Liposome's Influence on Brain Delivery of Diphenhydramine. Molecular Pharmaceutics |
| Vighi E, Trifunović D, Veiga-Crespo P, et al. (2018) Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration. Proceedings of the National Academy of Sciences of the United States of America |
| Kanhai KMS, Zuiker RGJA, Stavrakaki I, et al. (2018) Glutathione-PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first-in-human study. British Journal of Clinical Pharmacology. 84: 1020-1028 |
| Greenwood J, Hammarlund-Udenaes M, Jones HC, et al. (2017) Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017. Fluids and Barriers of the Cns. 14: 31 |
| Hu Y, Rip J, Gaillard PJ, et al. (2017) The Impact of Liposomal Formulations on the Release and Brain Delivery of Methotrexate: A In Vivo Microdialysis Study. Journal of Pharmaceutical Sciences |
| Maussang D, Rip J, van Kregten J, et al. (2016) Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo. Drug Discovery Today. Technologies. 20: 59-69 |
| Gaillard PJ. (2016) BBB crossing assessment and BBB crossing technologies in CNS Drug Discovery. Drug Discovery Today. Technologies. 20: 1-3 |
| Lindqvist A, Rip J, van Kregten J, et al. (2015) In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes. Pharmaceutical Research |